Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

President Trump's new Executive Order aims to lower prescription drug prices by tying U.S. costs to global rates. Read more ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...